Objective: To develop an intervention based on Notch-1 signalling pathway blockade by investigating the potential application of the neurogenic locus notch homologue protein 1(Notch-1) signalling pathway as a key regulator of chronic in ammation and adipogenesis in the treatment of hepatic insulin resistance (HIR). Study Design: Experimental study. Place and Duration of the Study: Animal Laboratory of the Fourth Hospital of Hebei Medical University,Shijiazhuang, China, from April 2021 to June 2022. Methodology: HIR models were established in Notch-1WT and Notch-1MAC-KO mice by high fat diet (HFD) for 16 weeks. Haematoxylin and eosin (HE) staining and oil red O (ORO) staining were used to detect in ammatory in ltration and lipid accumulation in each group. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of TNF-± and IL-6. Free fatty acid (FFA) and total cholesterol (TC) were measured with relevant kits. Moreover, real-time quantitative polymerase chain reaction (PCR) was performed to detect the relative expressions of F4/80, Mcp1, and CD11b in hepatic tissues. Mass spectrometry was used to analyse the levels of triglyceride (TG), diacylglycerol (DAG) and conformite europeenne (CE) in liver tissue. Western blotting was used to detect the expression of related proteins. Results: Speci c knockdown of Notch-1 in macrophages decreases the relative uorescence intensity of CD68 and attenuates in ammatory in ltration and lipid degeneration. There was no di erence in plasma levels of FFA and TG. Speci c knockdown of Notch-1 in macrophages decreases the expression of F4/80, Mcp1, and CD11b, as well as the levels of TG, DAG, CE, IL-6, and TNF-±. Conclusion: Speci c knockout of Notch-1 in macrophages may reduce HIR by inhibiting the IRE1±-XBP1 signalling pathway.